GP1BA and metabolic dysfunction-associated steatohepatitis: Genetic deficiency or blockade of GPIbα function using p0p6 antibody, which was earlier described as GPIbα and GPIX inhibitor (186, 187), suppressed NASH-inducing pathological effects, and this process was independent of the interactions of GPIbα with vWF, P-selectin, or αMβ2 integrin (186).